Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x

British Journal of Pharmacology

Volumn 128, Issue 5, 1999, Pages 945-952

  Zacharowski, Kai ^a   Otto, Mike ^b   Hafner, Gerd ^b   Marsh Jr , Henry C ^c   Thiemermann, Christoph ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c AVANT Immunotherapeutics Inc   (United States)

Author keywords

Complement system; Human soluble complement receptor 1; Myocardial ischaemia; Rat; Reperfusion; sCR1; sCR1sLe(x); Selectin adhesion molecules

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT INHIBITOR; NITROBLUE TETRAZOLIUM; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLYCOSYLATION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; GLYCOSYLATION; HEART RATE; HEMODYNAMIC PROCESSES; MALE; MONOCYTES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OLIGOSACCHARIDES; RATS; RATS, WISTAR; RECEPTORS, COMPLEMENT; RECOMBINANT PROTEINS; TROPONIN T;

EID: 0032754434     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702889     Document Type: Article

References (43)

1. ADAMS, J.E.D., ABENDSCHEIN, D.R. & JAFFE, A.S. (1993). Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation, 88, 750-763.
2. BALLER, D., BRETSCHNEIDER, H.J. & HELLIGE, G. (1981). A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res. Cardiol., 76, 163-181.
3. BIESECKER, G. & GOMEZ. C.M. (1989). Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. J. Immunol., 142, 2654-2659.
4. BUERKE, M., WEYRICH, A.S., ZHENG, Z., GAETA, F.C., FORREST, M.J. & LEFER, A.M. (1994). Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest., 93, 1140-1148.
5. BUTCHER, E.C. (1991). Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell, 67, 1033-1036.
6. CHAVEZ-CARTAYA, R.E., DESOLA, G.P., WRIGHT, L., JAMIESON, N.V. & WHITE, D.J. (1995). Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Transplantation, 59, 1047-1052.
7. COUSER, W.G., BAKER, P.J. & ADLER, S. (1985). Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int., 28, 879-890.
8. CRAWFORD, M.H., GROVER, F.L., KOLB, W.P., MCMAIIAN, C.A., O'ROURKE, R.A., MCMANUS, L.M. & PINCKARD, R.N. (1988). Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation, 78, 1449-1458.
9. ENGLER, R.L., DAHLGREN, M.D., PETERSON, M.A., DOBBS, A. & SCHMID-SCHONBEIN, G.W. (1986). Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am. J. Physiol., 251, H93-H100.
10. ENTMAN, M.L., MICHAEL, L., ROSSEN, R.D., DREYER, W.J., ANDERSON, D.C., TAYLOR, A.A. & SMITH, C.W. (1991). Inflammation in the course of early myocardial ischemia. FASEB. J., 5, 2529-2537.
11. FOXALL, C., WATSON, S.R., DOWBENKO, D., FENNIE, C., LASKY, L.A., KISO, M., HASEGAWA, A., ASA, D. & BRANDLEY, B.K. (1992). The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J. Cell Biol., 117, 895-902.
12. FRANK, M.M. (1987). Complement in the pathophysiology of human disease. N. Engl. J. Med., 316, 1525-1530.
13. HIDE, E.J., NEY, P., PIPER, J., THIEMERMANN, C. & VANE, J.R. (1995). Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br. J. Pharmacol., 116, 2435-2440.
14. HIDE, E.J. & THIEMERMANN, C. (1996). Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br. J. Pharmacol., 118, 1409-1414.
15. HIMMELFARB, J., MCMONAGLE, E., HOLBROOK, D. & TOTH, C. (1995). Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J. Lab. Clin. Med., 126, 392-400.
16. KATUS, H.A., REMPPIS, A., SCHEFFOLD, T., DIEDERICH, K.W. & KUEBLER, W. (1991). Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am. J. Cardiol., 67, 1360-1367.
17. KAWAKAMI, T., LOWBEER, C., VALEN, G. & VAAGE, J. (1999). Mechanical conversion of post-ischaemic ventricular fibrillation: effects on function and myocyte injury in isolated rat hearts [In Process Citation]. Scand. J. Clin. Lab. Invest., 59, 9-16.
18. KLONER, R.A., GIACOMELLI, F., ALKER, K.J., HALE, S.L., MATTHEWS, R. & BELLOWS, S. (1991). Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation, 84, 1758-1772.
19. MAIR, J., ARTNER-DWORZAK, E., LECHLEITNER, P., SMIDT, J., WAGNER, I., DIENSTL, F. & PUSCHENDORF, B. (1991). Cardiac troponin T in diagnosis of acute myocardial infarction [see comments]. Clin. Chem., 37, 845-852.
20. MAIR, J., GENSER, N., MORANDELL, D., MAIER, J., MAIR, P., LECHLEITNER, P., CALZOLARI, C., LARUE, C., AMBACH, E., DIENSTL, F., PAU, B. & PUSCHENDORF, B. (1996). Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin. Chim. Acta. 245, 19-38.
21. MULLANE, K.M., READ, N., SALMON, J.A. & MONCADA, S. (1984). Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther., 228, 510-522.
22. MULLIGAN, M.S., LOWE, J.B., LARSEN, R.D., PAULSON, J., ZHENG, Z.L., DEFREES, S., MAEMURA, K., FUKUDA, M. & WARD, P.A. (1993b). Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J. Exp. Med., 178, 623-631.
23. MULLIGAN, M.S., PAULSON, J.C., DE FREES, S., ZHENG, Z.L., LOWE, J.B. & WARD, P.A. (1993a). Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature, 364, 149-151.
24. MULLIGAN, M.S., YEH, C.G., RUDOLPH, A.R. & WARD, P.A. (1992). Protective effects of soluble CR1 in complement-and neutrophil-mediated tissue injury. J. Immunol., 148, 1479-1485.
25. NICKELLS, M., HAUHART, R., KRYCH, M., SUBRAMANIAN, V.B., GEOGHEGANBAREK, K., MARSH, H.C. & ATKINSON, J.P. (1998). Mapping epitopes for 20 monoclonal antibodies to CR1. Clin. Exp. Immun., 112, 27-33.
26. O'BRIEN, P.J., DAMERON, G.W., BECK, M.L., KANG, Y.J., ERICKSON, B.K., DI BATTISTA, T.H., MILLER, K.E., JACKSON, K.N. & MITTELSTADT, S. (1997). Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab. Anim. Sci., 47, 486-495.
27. OMURA, T., TERAGAKI, M., TAKAGI, M., TANI, T., NISHIDA, Y., YAMAGISHI, H., YANAGI, S., NISHIKIMI, T., YOSHIYAMA, M., TODA, I., ET AL (1995). Myocardial infarct size by serum troponin T and myosin light chain 1 concentration. Jpn. Circ. J., 59, 154-159.
28. PINCKARD, R.N., O'ROURKE, R.A., CRAWFORD, M.H., GROVER, F.S., MCMANUS, L.M., GHIDONI, J.J., STORRS, S.B. & OLSON, M.S. (1980). Complement localization and mediation of ischemic injury in baboon myocardium. J. Clin. Invest., 66, 1050-1056.
29. REIMER, K.A., MURRY, C.E. & RICHARD, V.J. (1989). The role of neutrophilis and free radicals in the ischemic-reperfused heart: why the confusion and controversy? J. Mol. Cell. Cardiol., 21, 1225-1239.
30. RITTERSHAUS, C.W., THOMAS, L.J., MILLER, D.P., PICARD, M.D., GEOGHEGAN-BAREK, K.M., SCESNEY, S.M., HENRY, L.D., SEN, A.C., BERTINO, A.M., HANNIG, G., ADARI, H., MEALEY, R.A., GOSSELIN, M.L., COUTO, M., HAYMAN, E.G., LEVIN, J.L., REINHOLD, V.N. & MARSH, JR. H.C. (1999). Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules. J. Biol. Chem., 274, 11237-11244.
31. SACKS, T., MOLDOW, C.F., CRADDOCK, P.R., BOWERS, T.K. & JACOB, H.S. (1978). Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J. Clin. Invest., 61, 1161-1167.
32. SCHAFER, H., MATHEY, D., HUGO, F. & BHAKDI, S. (1986). Deposition of the terminal C5b-9 complement complex in infarcted ureas of human myocardium. J. Immunol., 137, 1945-1949.
33. SCHREIBER, A.D. & FRANK, M.M. (1972). Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J. Clin. Invest., 51, 583-589.
34. SMITH, E.F.D., GRISWOLD, D.E., EGAN, J.W., HILLEGASS, L.M., SMITH, R.A., HIBBS, M.J. & GAGNON, R.C. (1993). Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730). Eur. J. Pharmacol., 236, 477-481.
35. VALEN, G., STARKOPF, J., TAKESHIMA, S., KULLISAAR, T., VIHALEMM, T., KENGSEPP, A.T., LOWBEER, C., VAAGE, J. & ZILMER, M. (1998). Preconditioning with hydrogen peroxide (H202) or ischemia in H202-induced cardiac dysfunction. Free Radic. Res., 29, 235-245.
36. WAGNER, I., MAIR, J., FRIDRICH, L., ARTNER-DWORZAK, E., LECHLEITNER, P., MORASS, B., DIENSTL, F. & PUSCHENDORF, B. (1993). Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coron. Artery Dis., 4, 537-544.
37. WEISER, M.R., WILLIAMS, J.P., MOORE, JR. F.D., KOBZIK, L., MA, M., HECHTMAN, H.B. & CARROLL, M.C. (1996). Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med., 183, 2343-2348.
38. WEISMAN, H.F., BARTOW, T., LEPPO, M.K., MARSH, JR. H.C., CARSON, G.R., CONCINO, M.F., BOYLE, M.P., ROUX, K.H., WEISFELDT, M.L. & FEARON, D.T. (1990). Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science, 249, 146-151.
39. WERNS, S.W. & LUCCHESI, B.R. (1988). Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion. Free Radic. Biol. Med., 4, 31-37.
40. WEYRICH, A.S., BUERKE, M., ALBERTINE, K.H. & LEFER, A.M. (1995). Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J. Leukoc. Biol., 57, 45-55.
41. YASUDA, M., TAKEUCHI, K., HIRUMA, M., IIDA, H., TAHARA, A., ITAGANE, H., TODA, I., AKIOKA, K., TERAGAKI, M. & OKU, H. (1990). The complement system in ischemic heart disease. Circulation, 81, 156-163.
42. ZACHAROWSKI, K., OLBRICH, A., OTTO, M., HAFNER, G. & THIEMERMANN, C. (1999a). Effects of the prostanoid EP3-receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat. Br. J. Pharmacol., 126, 849-858.
43. ZACHAROWSKI, K., OLBRICH, A. & THIEMERMANN, C. (1999b). Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels. Eur. J. Pharmacol., 367, 33-39.